# ADDYI
> **NDA022526** · New Drug Application · Sponsor: SPROUT PHARMS · Approved 2015-08-18
## Drug
- **FDA Application Number:** NDA022526
- **Application type:** New Drug Application
- **Brand name:** ADDYI
- **Generic name:** FLIBANSERIN
- **Active ingredients:** FLIBANSERIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SPROUT PHARMS
- **Manufacturer:** Sprout Pharmaceuticals, Inc.
- **First approval:** 2015-08-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022526)
---
*AI Analytics · CC0 1.0*